fIPV (0.1mL) IM — Competitive Intelligence Brief

fIPV (0.1mL) IM (fIPV (0.1mL) IM) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: inactivated viral vaccine. Area: Immunology / Infectious Disease.

marketed inactivated viral vaccine poliovirus serotypes 1, 2, and 3 Immunology / Infectious Disease Biologic

Target snapshot

fIPV (0.1mL) IM (fIPV (0.1mL) IM) — Centers for Disease Control and Prevention. fIPV is an inactivated polio vaccine that stimulates the immune system to produce antibodies against all three poliovirus serotypes, preventing poliomyelitis infection.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
fIPV (0.1mL) IM TARGET	fIPV (0.1mL) IM	Centers for Disease Control and Prevention	marketed	inactivated viral vaccine	poliovirus serotypes 1, 2, and 3
Sabin IPV + Sabin IPV + Sabin IPV	Sabin IPV + Sabin IPV + Sabin IPV	Zhejiang Provincial Center for Disease Control and Prevention	marketed	inactivated viral vaccine	poliovirus serotypes 1, 2, and 3
vaccinated with Sabin IPV	vaccinated with Sabin IPV	Zhejiang Provincial Center for Disease Control and Prevention	marketed	vaccine	poliovirus serotypes 1, 2, and 3
IPV-Al	IPV-Al	AJ Vaccines A/S	marketed	Inactivated viral vaccine	Poliovirus serotypes 1, 2, and 3
Sabin IPV	Sabin IPV	Centers for Disease Control and Prevention, China	marketed	inactivated viral vaccine	poliovirus serotypes 1, 2, and 3
IPV SSI	IPV SSI	Statens Serum Institut	phase 3	Inactivated viral vaccine	Poliovirus serotypes 1, 2, and 3
TBE booster vaccination	TBE booster vaccination	Medical University of Vienna	marketed	Inactivated viral vaccine	Tick-borne encephalitis virus envelope proteins

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (inactivated viral vaccine class)

1. Sinovac Biotech Co., Ltd · 5 drugs in this class
2. Sinovac Research and Development Co., Ltd. · 2 drugs in this class
3. Sanofi Pasteur, a Sanofi Company · 2 drugs in this class
4. Federal University of Espirito Santo · 1 drug in this class
5. International Vaccine Institute · 1 drug in this class
6. MacroGenics · 1 drug in this class
7. Shandong Province Centers for Disease Control and Prevention · 1 drug in this class
8. Beijing Chaoyang District Centre for Disease Control and Prevention · 1 drug in this class
9. Zhejiang Provincial Center for Disease Control and Prevention · 1 drug in this class
10. Centers for Disease Control and Prevention · 1 drug in this class